Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participant with Grade I or Grade II acute sprain of the lateral ankle within 24 hours before screening visit~* Participant with self-assessed pain intensity score after movement (5 steps) at the site of the ankle sprain that is \>= 5 as measured on a 0-10 NRS rating.~* Participant with a peri-malleolar edema (sub-malleolar perimeter difference of \>=20mm between injured and uninjured ankle)~Exclusion Criteria:~* Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.~* Participant who had medication that could interfere with the subject's perception of pain since experiencing ankle sprain.~* Pregnancy , Breast Feeding and Substance Abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Indomethacin patch (Type: EXPERIMENTAL): Indomethacin patch to be applied on the sprained ankle twice a day (BID).
- Placebo patch (Type: PLACEBO_COMPARATOR): Placebo patch to be applied on the sprained ankle BID.

Based on this trial design, predict the completion outcome and termination type (if applicable).